Current studies primarily explore the relationships between clinical characteristics and patient outcomes, such as age, gender, tumor size, metastatic status (including lymph node involvement), positive tumor margins, and Ki‐67 index [13, 55, 65, 66, 67, 68, 69, 70, 71, 72]. This evidence concerns the gene MKI67 and neoplasm.